V212-001 A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients With Solid Tumor or Hematologic Malignancy

drug protocol number
V212-011
drug sponsor
MSD
drug study
V212
drug trial site
KFSH
drug status
Completed
drug phase